Skip to main content

Table 4 Association of cardiometabolic diseases (CMD) status and cognitive reserve (CR) level with neuroimaging measures

From: High cognitive reserve attenuates the risk of dementia associated with cardiometabolic diseases

CMD and CR status

No. of subjects

Markers of Neurodegeneration

 

Markers of Vascular Damage

Gray Matter Volume

Hippocampal Volume

 

White Matter Hyperintensity Volume

Fractional Anisotropy

Mean Diffusivity

β (95% CI)

β (95% CI)

 

β (95% CI)

β (95% CI)

β (95% CI)

CMD status

       

CMD-free

11,880

Reference

Reference

 

Reference

Reference

Reference

CMDs

1,783

-0.18 (-0.22, -0.13)

-0.13 (-0.18, -0.08)

 

0.06 (0.02, 0.11)

-0.05 (-0.11, 0.01)

0.08 (0.02, 0.13)

CR level

       

Low CR

1,499

Reference

Reference

 

Reference

Reference

Reference

Moderate CR

5,147

0.13 (0.08, 0.18)

0.06 (0.01, 0.12)

 

0.00 (-0.05, 0.05)

-0.03 (-0.09, 0.03)

0.05 (-0.02, 0.11)

High CR

7,017

0.27 (0.22, 0.32)

0.14 (0.09, 0.20)

 

0.00 (-0.05, 0.05)

0.02 (-0.04, 0.08)

0.05 (-0.01, 0.11)

Joint Exposure

       

CMDs

CR level

       

CMD-free

High

6,171

Reference

Reference

 

Reference

Reference

Reference

CMD-free

Moderate

4,430

-0.13 (-0.16, -0.09)

-0.07 (-0.11, -0.03)

 

0.00 (-0.03, 0.04)

-0.05 (-0.09, -0.01)

0.01 (-0.03, 0.05)

CMD-free

Low

1,279

-0.26 (-0.31, -0.21)

-0.11 (-0.17, -0.05)

 

0.00 (-0.06, 0.05)

-0.02 (-0.08, 0.04)

-0.06 (-0.13, -0.01)

CMDs

High

846

-0.14 (-0.20, -0.08)

-0.07 (0.14, -0.01)

 

0.07 (0.00, 0.13)

-0.06 (-0.14, 0.02)

0.10 (0.02, 0.17)

CMDs

Moderate

717

-0.33 (-0.39, -0.26)

-0.21 (-0.29, -0.14)

 

0.05 (-0.01, 0.12)

-0.09 (-0.18, -0.01)

0.06 (-0.03, 0.14)

CMDs

Low

220

-0.47 (-0.58, -0.36)

-0.42 (-0.55, -0.29)

 

0.08 (-0.04, 0.20)

-0.09 (-0.23, 0.06)

0.05 (-0.19, 0.20)

  1. All models were adjusted for age at baseline, sex, race/ethnicity, socioeconomic status, body mass index, smoking status, alcohol drinking, physical activity, hypertension, depression, APOE ε4 carrier status, and MRI-reflated factors (head position, scanner table position, and assessment center)